OKLO
Oklo Inc.Thesis. OKLO is a pre-revenue Aurora Powerhouse developer trading 75% below its $193.84 high with $2.21B net cash and near-zero debt — a rare combination of blown-out sentiment and a fully funded runway. The Groves Isotope Test Reactor's DOE safety approval is the first hard de-risking milestone, and a 19-analyst buy consensus targets $88.63 (85% upside), but insider net selling of $17.8M and a 25% EPS beat rate argue for tranched accumulation, not a full-size bet.
Scoreboard
OKLO trades at $47.90, down 75.3% from its $193.84 52-week high and just 6.7% above the $44.88 low — pinned at the 2nd percentile of its annual range and far below the 50-day ($62.95) and 200-day ($83.54) averages. The $8.33B equity cap sits against a $6.13B enterprise value, reflecting $2.21B of net cash. Consensus mean target of $88.63 (median $84, high $140, low $14) implies 85% upside across 19 analysts at a 2.0 buy-tilted recommendation mean — one of the widest price-to-rating dislocations in the SMR complex.
QoQ Changes
OKLO remains pre-revenue: Q1 2026 (Mar-31) again printed $0.00 total revenue, consistent with every quarter in the trailing set. Basic EPS of -$0.19 narrowed from Q4 2025's -$0.27 and beat the -$0.1966 estimate by 3.4% — the first beat in four quarters.
Margin analysis is moot with zero revenue; the read-through is the operating-loss run-rate. Q1 2026 operating loss of $51.2M and EBITDA of -$51.1M improved sequentially from Q4's -$57.1M and -$56.9M, but both are materially wider than the -$28.0M posted in Q2 2025 — cash burn is scaling with headcount and reactor development.
Free cash flow yield runs -1.2% against the current market cap, with quarterly cash burn near $30-50M at the net-income line. With $2.21B of cash on hand, the implied runway extends multiple years even at an accelerating spend rate — funding is not the near-term risk.
The balance sheet is the core of the bull case: $2.21B total cash versus only $2.62M total debt yields $2.21B net cash ($12.69/share) and a 0.099 debt/equity ratio. Liquidity is extreme — current ratio 59.9x, quick ratio 59.7x — leaving OKLO fully funded through its pre-commercial phase.
With no revenue, conventional multiples break down: forward P/E is -57.9x, EV/EBITDA -35.6x, and price/book 3.16x on a $15.18 book value. The $8.33B cap is entirely an option premium on Aurora deployment and fuel-recycling optionality, not on in-place cash flows.
OKLO acquired sodium-engineering firm CEI to bring critical Aurora engineering in-house and accelerate deployment, and secured DOE Documented Safety Analysis approval for the Groves Isotope Test Reactor in Texas, targeting startup this month. Headcount stands at 215 as the company builds execution capacity ahead of first commercial reactors.
Ownership & Insider Activity
Finnhub SEC Form 4 data shows net insider selling of $17.8M over the ~60-day window, led entirely by CFO Bealmear, who exercised options (code M) and sold on the open market (code S) — 46,843 shares at $69.42 (~$3.25M) and 10,000 at $69.31 (~$693K) on June 1, alongside a 2,100-share gift (code G). All director activity was routine equity awards (code A): eight directors each granted 3,213 shares on June 11 at $0 cost — compensation, not conviction. Encouragingly, short interest fell to 27.2M shares from 35.1M the prior month (17.9% of float, 1.93-day cover), signaling active covering into the drawdown.
Recent Insider Transactions
| Date | Insider | Position | Shares | Value |
|---|---|---|---|---|
| 2026-07-01 | DEWITTE JACOB | Chief Executive Officer | 200,000 | $10.6M |
| 2026-07-01 | COCHRAN CAROLINE | Chief Operating Officer | 200,000 | $10.6M |
| 2026-06-02 | BEALMEAR RICHARD CRAIG | Chief Financial Officer | 122,096 | $388.3K |
| 2026-06-01 | BEALMEAR RICHARD CRAIG | Chief Financial Officer | 2,100 | $0.00 |
| 2026-06-01 | BEALMEAR RICHARD CRAIG | Chief Financial Officer | 73,081 | $5.0M |
| 2026-06-01 | DEWITTE JACOB | Chief Executive Officer | 200,000 | $13.7M |
Earnings Quality
| Period | Actual EPS | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
| 2026-03-31 Q1 | $-0.19 | $-0.20 | +$0.01 | +3.36% |
| 2025-12-31 Q4 | $-0.27 | $-0.17 | $-0.10 | -56.16% |
| 2025-09-30 Q3 | $-0.20 | $-0.13 | $-0.07 | -49.37% |
| 2025-06-30 Q2 | $-0.18 | $-0.11 | $-0.07 | -61.00% |
OKLO beat consensus in just 1 of the last 4 quarters (25% beat rate) with an average surprise of -40.8%, including a -61.0% miss in Q2 2025 and -56.2% in Q4 2025 — a pattern of analysts under-modeling the cash-burn ramp rather than execution surprise, since there is no revenue line to beat.
The Q1 2026 +3.4% surprise breaks a three-quarter string of large misses, suggesting analyst loss estimates are finally recalibrating toward the true spend trajectory — a modest improvement in guidance visibility, though with zero revenue the signal remains thin.
Analyst Action
| Month | Distribution | Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|---|---|
| 2026-07 | 5 | 15 | 9 | 1 | 0 | |
| 2026-06 | 5 | 15 | 8 | 1 | 0 | |
| 2026-05 | 5 | 16 | 6 | 1 | 0 | |
| 2026-04 | 5 | 14 | 6 | 1 | 0 |
The Finnhub recommendation series shows steady, mildly bullish drift: Strong Buy held at 5 across April-July 2026, Buy ticked from 14 (April) to 15 (June-July), while Hold expanded from 6 to 9 and a lone Sell persisted — net a broadening of coverage with the bullish core intact.
Momentum is marginally bullish, with the Buy/Strong-Buy bloc (20) still dominating a growing Hold camp (9), and zero downgrades in the trailing 15-day window.
Seven Essential Metrics
Pre-revenue with 0% reported margins, ROE -8.87% and ROA -7.18%; Q1 2026 EBITDA of -$51.1M reflects a widening pre-commercial loss.
Revenue growth n/a — zero revenue across all four reported quarters; the entire thesis is forward optionality on Aurora deployment, not current growth.
FCF yield -1.2% with quarterly cash burn of ~$30-50M, though the $2.21B cash pile makes the burn easily fundable for years.
Net cash of $2.21B ($12.69/share) against $2.62M total debt and a 0.099 debt/equity ratio — a debt-free, over-capitalized balance sheet.
Beta 1.16 understates true risk: pre-revenue binary regulatory outcomes, a 75% drawdown from highs, and 17.9% short interest of float.
Negative fwd P/E (-57.9x) and EV/EBITDA (-35.6x) with 3.16x book on an $8.33B cap and zero revenue — priced entirely on optionality.
Former SPAC funding development via equity; ongoing option exercises and director/officer share awards structurally add to the ~174M share count.
Zero capital returns; all cash is retained to fund reactor commercialization.
Competitive Snapshot
| Company | EBITDA Margin | 3Y Rev CAGR | FCF Margin | Leverage | Fwd P/E |
|---|---|---|---|---|---|
SMR NuScale Power | Negative | ~early-stage | Negative | Net cash | n/a (loss) |
NNE Nano Nuclear Energy | Negative | Pre-revenue | Negative | Net cash | n/a (loss) |
BWXT BWX Technologies | ~19% | ~8% | ~10% | ~1.5x | ~30x |
LEU Centrus Energy | ~15% | ~20% | ~10% | <1x | ~20x |
OKLO sits at the highest-risk, highest-optionality end of the nuclear spectrum: like SMR and NNE it is pre-revenue and burns cash, but its $2.21B net cash dwarfs most SMR-stage peers and removes financing risk. Against cash-generative incumbents BWXT and LEU — which trade on real earnings at ~20-30x forward — OKLO offers no valuation anchor, only a call option on being first to a commercial fast reactor. Its differentiation is the fuel-recycling angle and Aurora's 15-75 MW modular scale, but that premium is only justified if regulatory milestones convert on schedule.
Business & Strategy
Revenue is currently $0: OKLO's model is to build, own, and operate Aurora Powerhouse fission plants (15-75 MW) and sell electricity under long-term power purchase agreements rather than sell reactors outright. A second leg — nuclear fuel recycling and fabrication converting used fuel into Aurora feedstock — is being commercialized in parallel. The Groves Isotope Test Reactor adds a near-term isotope-production optionality.
Target customers are data centers, hyperscalers, industrial sites, and defense/government installations seeking firm, carbon-free baseload power for AI-driven demand.
Primary future stream is recurring PPA electricity sales (a utility-like, contracted cash-flow profile); secondary streams are fuel-recycling services and medical/industrial isotope sales from Groves.
Costs are dominated by R&D, reactor engineering, NRC/DOE licensing, sodium-coolant supply chain, and the in-house engineering now added via the CEI acquisition.
The moat, if realized, is regulatory-and-first-mover: NRC licensing is a multi-year barrier that few competitors can clear, and vertical integration into fuel recycling would lock in a proprietary fuel-cost advantage. Today that moat is prospective — it does not exist until the first Aurora is operating and generating contracted revenue.
Monetary-Policy Sensitivity
- Long-duration, pre-cash-flow equity — valuation is highly sensitive to the discount rate
- Lower financing costs ease future project capex funding
- Risk-on rotation into speculative growth/nuclear names
As a zero-earnings, all-terminal-value name, OKLO is one of the most rate-sensitive stocks in the sector — its worth is a discounted stream of cash flows years out, so falling rates disproportionately lift the present value. A dovish pivot would also reopen risk appetite for the SMR complex that drove the 2025 run and compress the current sentiment discount.
SWOT Analysis
- $2.21B net cash ($12.69/share) with near-zero debt — fully funded multi-year runway
- First-mover Aurora fast-reactor design plus vertically integrated fuel-recycling optionality
- Groves DOE safety approval — first hard regulatory de-risking milestone
- Buy-tilted 19-analyst consensus with $88.63 mean target (85% upside)
- Zero revenue and widening operating losses (-$51.2M in Q1 2026)
- 25% EPS beat rate with -40.8% average surprise — poor guidance calibration
- $17.8M of net insider selling led by the CFO
- No commercial reactor operating; entire valuation is optionality
- Structural AI/data-center power demand driving hyperscaler PPA appetite
- Supportive Trump-administration policy push for small reactor deployment
- Groves isotope production as a nearer-term revenue seed
- Short interest at 17.9% of float — covering fuel if milestones hit
- NRC/DOE licensing delays or rejection — a binary downside catalyst
- Well-capitalized competition (BWXT, NuScale, Standard Nuclear IPO) and new entrants
- Equity dilution risk if capex outpaces the current cash pile
- Sentiment reversal in speculative nuclear names — stock already -75% from highs
Catalysts & Event Risks
- Q3 2026Groves reactor startup
First criticality/startup of the Groves Isotope Test Reactor, guided to go live within the month — the nearest-term proof point.
- Q3 2026Q2 2026 earnings
Next quarterly print; focus on cash burn trajectory, runway, and any customer/PPA announcements.
- Q4 2026Aurora NRC licensing progress
Any advance in Aurora Powerhouse combined-license or DOE pathway milestones would materially re-rate the terminal-value case.
- Q4 2026Hyperscaler / data-center PPA
A firm power-purchase agreement with a named AI/data-center counterparty would convert optionality into contracted revenue visibility.
- 2026-09-18FOMC rate decision
A dovish shift would disproportionately lift this long-duration, pre-earnings equity.
The catalyst path is front-loaded and binary: Groves startup is imminent and largely de-risked, but the value-defining events are Aurora licensing and a first commercial PPA, both of which remain months to quarters out. Expect the stock to trade on milestone headlines with high volatility around each.
Technical Analysis
OKLO is in a clear downtrend, sitting at the 2nd percentile of its 52-week range and testing the $44.88 low, with price ($47.90) below both the 50-day ($62.95) and 200-day ($83.54) averages. The 75% drawdown from $193.84 has washed out momentum longs, and the recent DOE-approval bounce failed to reclaim the 50-day — the first resistance to watch. Falling short interest (27.2M from 35.1M) removes some downside fuel, and the proximity to the annual low offers an asymmetric risk-reward for tranched entry: a hold of $44.88 sets up a mean-reversion toward $62-70, while a breakdown opens air toward the low-$40s. Risk-reward favors accumulating near support with tight thesis discipline, not chasing strength.
Verdict
Macro context. The macro backdrop is favorable in narrative but unproven in cash flows: AI-driven power demand and a policy tailwind for small reactors underpin the sector, while a potential rate-cutting cycle would lift long-duration equities like OKLO disproportionately. The offset is a crowded, capital-hungry SMR field — the Standard Nuclear IPO ($383M raise) signals both validation and rising competition for capital and customers.
OKLO is a fully funded call option on the SMR/AI-power thesis now trading at a 75% discount to its high with $2.21B of net cash removing financing risk — a rare setup where sentiment has overshot the fundamentals. The bear points are real: zero revenue, widening losses, a 25% beat rate, and $17.8M of CFO-led insider selling. But with Groves de-risked, a buy-tilted consensus targeting 85% upside, and the stock pinned at its 52-week low, we rate OKLO ACCUMULATE with a $70 target (46% upside), sized as a speculative position and built in tranches given the binary regulatory catalysts ahead.
Data source: Yahoo Finance / yfinance · fetched 7/8/2026, 6:53:44 AM